Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2025-11-24 00:00:00 ET · period of report 2025-11-21 · accession 0001628280-25-053877 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-24 | 2025-11-21 | SUPN | NEWHALL CHARLES W III | Dir | M - OptEx | $12.98 | +15.0K | 119.6K | +14% | +$194.7K |
| D | 2025-11-24 | 2025-11-21 | SUPN | NEWHALL CHARLES W III | Dir | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-21 | M | A | 15,000 | $12.98 | 119,644 | D | — | — | |
| 2 | Derivative | Director Stock Option (Right to Buy) | 2025-11-21 | M | D | 15,000 | $0.00 | 0 | D | $12.98 · 2017-03-01 to 2026-03-01 | 15,000 Common Stock |